Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
Wendi S. Lambert(Vanderbilt University Medical Center), David J. Calkins(Vanderbilt University Medical Center)
Cited by 30
Related Papers
Solving neurodegeneration: common mechanisms and strategies for new treatments
|Molecular Neurodegeneration|2022|297
Bax Contributes to Retinal Ganglion Cell Dendritic Degeneration During Glaucoma
|Molecular Neurobiology|2022|33
Towards A Microbead Occlusion Model of Glaucoma for a Non-Human Primate
|Scientific Reports|2019|32
Of Mice and Monkeys: Neuroprotective Efficacy of the p38 Inhibitor BIRB 796 Depends on Model Duration in Experimental Glaucoma
|Scientific Reports|2020|21
Neutral sphingomyelinase inhibition promotes local and network degeneration in vitro and in vivo
|Cell Communication and Signaling|2023|20